Strategies to influence PVR development

被引:71
作者
Kirchhof, B [1 ]
机构
[1] Univ Cologne, Ctr Ophthalmol, Dept Vitreo Retinal Surg, D-50931 Cologne, Germany
关键词
D O I
10.1007/s00417-004-0978-8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Proliferative vitreo-retinopathy (PVR) is a complication of rhegmatogenous retinal detachment or severe ocular trauma (intraocular foreign body, penetration, perforation, contusion, rupture). The risk of PVR varies from 10 to 40% depending on the original disease. Strategies to influence the risk of PVR include surgical techniques, pharmacological adjuncts, and preventive measurements. Surgical influences on the risk of PVR comprise: surgical skills (buckling, atraumatic procedure), primary vitrectomy, early vitrectomy, retinectomy, choice of vitreous tamponade agent. The influence of most such parameters is not confirmed by prospective randomized studies. Pharmaceutical adjuncts include daunomycin, 5-fluoruracil plus heparin and others. The influence of most such parameters has been studied by prospective randomized studies. The effect is statistically significant, its clinical relevance is subject of current discussion. Prevention of PVR, via prevention of injury, was successful in the past as shown by the reduction of wind screen injuries after the seatbelt legislation was installed, and reduction of work related injuries from protective eyewear. As for the treatment of existent PVR despite some progress in the past, there should be better ways of treatment ahead of us.
引用
收藏
页码:699 / 703
页数:5
相关论文
共 48 条
[1]   One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration [J].
Abdel-Meguid, A ;
Lappas, A ;
Hartmann, K ;
Auer, F ;
Schrage, N ;
Thumann, G ;
Kirchhof, B .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (05) :615-621
[2]   Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: Results of additional and long-term follow-up - Silicone study report 11 [J].
Abrams, GW ;
Azen, SP ;
McCuen, BW ;
Flynn, HW ;
Lai, MY ;
Ryan, SJ .
ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (03) :335-344
[3]  
Aisenbrey S, 2002, ARCH OPHTHALMOL-CHIC, V120, P451
[4]   Adjuvant 5-FU and heparin prevent PVR [J].
Allinson, RW .
OPHTHALMOLOGY, 2002, 109 (05) :829-830
[5]   Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy - Results from a randomized, double-blind, controlled clinical trial [J].
Asaria, RHY ;
Kon, CH ;
Bunce, C ;
Charteris, DG ;
Wong, D ;
Khaw, PT ;
Aylward, GW .
OPHTHALMOLOGY, 2001, 108 (07) :1179-1183
[6]   Primary vitrectomy for pseudophakic retinal detachment [J].
BartzSchmidt, KU ;
Kirchhof, B ;
Heimann, K .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1996, 80 (04) :346-349
[7]   RADIATION-THERAPY IN PROLIFERATIVE VITREORETINOPATHY - A PROSPECTIVE RANDOMIZED STUDY [J].
BINDER, S ;
BONNET, M ;
VELIKAY, M ;
GERARD, JP ;
STOLBA, U ;
WEDRICH, A ;
HOHENBERG, H .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1994, 232 (04) :211-214
[8]   Primary vitrectomy with perfluoro-n-octane use in the treatment of pseudophakic retinal detachment with undetected retinal breaks [J].
Brazitikos, PD ;
D'Amico, DJ ;
Tsinopoulos, IT ;
Stangos, NT .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1999, 19 (02) :103-109
[9]   Post traumatic proliferative vitreoretinopathy - The epidemiologic profile, onset, risk factors, and visual outcome [J].
Cardillo, JA ;
Stout, JT ;
LaBree, L ;
Azen, SP ;
Omphroy, L ;
Cui, JZ ;
Kimura, H ;
Hinton, DR ;
Ryan, SJ .
OPHTHALMOLOGY, 1997, 104 (07) :1166-1173
[10]   EARLY VITRECTOMY IN THE MANAGEMENT OF THE SEVERELY TRAUMATIZED EYE [J].
COLEMAN, DJ .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 93 (05) :543-551